MA
Not verified

MAS Capital

What we write about

BiotechnologyFinanceHealthPharmaceuticalsStocks and shares
21/04/2026
Stocks and shares
Associations / Professional
Health
Finance
Sanità
Organizzazione Aziendale
Pharmaceuticals
Biotechnology
Advised by MAS Capital, Suntec Medical Plans for a US$100M Nasdaq IPO in 2027
1.00

Contact details

Social Media

Followers
0
Compatibility
0